Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Preferred Shares (2020 - 2021)

Treace Medical Concepts' Preferred Shares history spans 2 years, with the latest figure at $7.9 million for Q1 2021.

  • For Q1 2021, Preferred Shares changed N/A year-over-year to $7.9 million; the TTM value through Mar 2021 reached $7.9 million, changed N/A, while the annual FY2020 figure was $7.9 million, N/A changed from the prior year.
  • Preferred Shares reached $7.9 million in Q1 2021 per TMCI's latest filing, roughly flat from $7.9 million in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $7.9 million in Q4 2020 to a low of $7.9 million in Q4 2020.